54
Artificial intelligence (AI) is revolutionizing oncology research through advanced analysis of large volumes of biomedical data, improving diagnostic accuracy and personalizing therapies for patients. AI techniques, such as machine learning and neural networks, are used to identify new therapeutic targets and predict treatment response, helping to optimize clinical outcomes. These tools not only accelerate the discovery and development of new anticancer drugs, but also support doctors in clinical decisions, improving the quality of cancer care. They talk about it Giuseppe Curiglianomember of the National Aiom Board, e Massimo Di Maiopresident-elect Aiom.
Subjects